What Is Semax? The Nootropic Peptide From Russia

Most mechanism research comes from rodent studies. The main proposed effects are:

• BDNF increase: Semax raised levels of brain-derived neurotrophic factor (BDNF) and its receptor TrkB in the rat hippocampus. BDNF supports the survival and connections of neurons.
• Neurotransmitter effects: animal studies report changes in dopamine and serotonin activity.
• Gene expression after ischemia: in rat stroke models, Semax shifted the activity of genes involved in inflammation and blood vessel function.

Stroke recovery. Semax is approved in Russia for stroke and other conditions of reduced blood flow to the brain. Russian clinical studies report faster neurological recovery when it is added to standard care. Most of these trials were small, not always blinded, and published in Russian-language journals, which makes them hard to evaluate.

Cognition. Animal studies show improved learning and memory. Small human studies in Russia reported better attention and short-term memory, but there are no large, independent placebo-controlled trials in healthy people.

What the FDA reviewed. For the July 2026 meeting, the FDA evaluated Semax for cerebral ischemia (reduced brain blood flow), migraine and trigeminal neuralgia.

Russian clinical use suggests Semax is generally well tolerated. Reported effects include nasal irritation and, less often, headache or feeling overstimulated. However, formal safety data in Western populations are minimal, and long-term effects are not well characterized.

On July 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee voted 8–5 to recommend adding Semax (free base and acetate forms) to the 503A Bulks List. FDA staff had recommended against it.

• The recommendation is non-binding.
• Semax is not FDA-approved.
• The FDA must complete rulemaking before compounding pharmacies can legally use it.

Semax is often compared with other peptide and non-peptide nootropics:

N-Acetyl Semax Amidate. This version adds an acetyl group to one end and an amide group to the other, a common trick to slow breakdown. It is popular with research suppliers, but almost all published data are on regular Semax, so claims about the modified form are largely extrapolated.

Semax vs Selank. The two come from the same Russian institute and share the same Pro-Gly-Pro tail. Semax is generally described as activating and focus-oriented, while Selank is calming. Some suppliers sell them pre-blended, which has not been studied as a combination.

Products sold as Semax by research suppliers are laboratory chemicals, not medicines. They are not made under drug manufacturing rules, so quality varies a lot between vendors. If you are evaluating a Semax supplier for lab research, these are the checks that matter:

• Batch-specific COA: the certificate should match the lot number on your vial, not a generic sample.
• Independent lab: testing should come from a named third-party lab, ideally with a way to verify the report online.
• Identity, not just purity: HPLC purity alone does not confirm the right molecule; look for mass spectrometry (MS) identity confirmation.
• Endotoxin and sterility results: these matter for any injectable research material.
• Correct fill amount: the measured content should be close to the labeled milligrams.

Our Trusted Sources page lists vendors we track, with current community codes. Our guide to reading a certificate of analysis explains each line of a COA.

• Semax is a seven-amino-acid peptide based on a fragment of ACTH, without ACTH’s cortisol effects.
• Animal studies show increased BDNF, which supports neuron growth and survival.
• It is approved in Russia for stroke, but supporting trials are small.
• There are no large independent trials in healthy people.
• An FDA panel recommended it for compounding in 2026; it is not FDA-approved.

What is Semax?

Semax is a seven-amino-acid peptide based on a fragment of ACTH. It was developed in Russia, where it is used as nasal drops, mainly for stroke recovery.

Does Semax increase BDNF?

In rat studies, Semax increased BDNF and its receptor TrkB in the hippocampus. This has not been confirmed in large human studies.

Does Semax raise cortisol like ACTH?

No. Semax uses a fragment of ACTH that does not stimulate the adrenal glands to release cortisol.

Is Semax FDA-approved?

No. An FDA advisory committee voted 8–5 in July 2026 to recommend it for the compounding list, but the FDA has not finalized that and Semax is not an approved drug.

What is the difference between Semax and Adamax?

Adamax is a modified version of Semax with an added chemical group intended to increase stability. It has far less published research. See our Semax vs Adamax guide.

• Dolotov et al. (2006) – Semax increases BDNF and TrkB expression in rat hippocampus
• Regulatory Affairs Professionals Society – FDA advisory committee backs Epitalon and Semax, rejects emideltide (July 2026)
• McDermott Will & Schulte – PCAC backs majority of peptides in two-day public meeting (2026)
• JD Bioworks – FDA peptide compounding vote explained (2026)